June 24, 2017 12:19 AM ET

Biotechnology

Company Overview of Vedanta Biosciences, Inc.

Company Overview

Vedanta Biosciences, Inc. develops treatments for human diseases by studying the relationship between microbes and human immune system. The company was incorporated in 2010 and is based in Boston, Massachusetts. Vedanta Biosciences, Inc. operates as a subsidiary of PureTech Health PLC.

Boston, MA 

United States

Founded in 2010

Key Executives for Vedanta Biosciences, Inc.

Chief Executive Officer
Compensation as of Fiscal Year 2016.

Vedanta Biosciences, Inc. Key Developments

Vedanta Biosciences, Inc. Presents at Boston CEO Conference, May-30-2017 01:50 PM

Vedanta Biosciences, Inc. Presents at Boston CEO Conference, May-30-2017 01:50 PM. Venue: Four Season Boston, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Bernat Olle, Chief Executive Officer.

Vedanta Biosciences, Inc. Presents at Jefferies 2017 Global Healthcare Conference, Jun-07-2017 09:30 AM

Vedanta Biosciences, Inc. Presents at Jefferies 2017 Global Healthcare Conference, Jun-07-2017 09:30 AM. Venue: Grand Hyatt, 109 E 42nd St, New York, New York, United States. Speakers: Jonathan Freeman, Chief Business Officer.

Vedanta Biosciences, Inc. Announces Collaborations with Stanford University School of Medicine and Leiden University Medical Center

Vedanta Biosciences, Inc. announced the translational medicine collaborations with Stanford University School of Medicine and Leiden University Medical Center. Under the terms of the agreement with Stanford, Vedanta will analyse changes in the gut microbiome as they relate to responses to oral immunotherapies in children with food allergies. With Leiden University, Vedanta will generate clinical data from interventional studies of faecal transplantation in C. difficile patients, as well as clinical data from patients with graft-versus-host disease. Both collaborations seek to better understand patterns in the microbiome that can potentially inform clinical responses to therapy and support Vedanta's ongoing drug development strategy. Both collaborations seek to better understand patterns in the microbiome that may potentially inform clinical responses to therapy. Under the terms of the agreement with Stanford, Vedanta will work in collaboration with Kari Nadeau, MD, PhD, Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, to analyse the potential connection between the gut microbiome and responses to oral immunotherapies in children with food allergies. With Leiden University, Vedanta will generate clinical data from interventional studies of faecal transplantation in C. difficile patients treated with donors from the Netherlands Donor Faeces Bank, as well as clinical data from patients with graft-versus-host disease, in collaboration with Ed Kuijper, MD, PhD, Professor of Medical Microbiology at the Leiden University Medical Center and co-chair of the Netherlands Donor Faeces Bank. The clinical data will feed into Vedanta's leading platform for discovery, development, and GMP manufacturing of rationally designed bacterial consortia drugs.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Vedanta Biosciences, Inc., please visit www.vedantabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.